Human Insulin-Induced Lipoatrophy: A successful treatment with glucocorticoid

With the arrival of human insulin, lipoatrophy has decreased dramatically, becoming a rare problem in clinical practice. Here, Ramos and Farias present a case of localized lipoatrophy in a patient treated with human insulin since the onset of type 1 diabetes when the application of betamethasone was effective in stopping and reversing this abnormality. Results indicate that, since the advent of human insulin and insulin analogs, an important reduction in the number of people with lipoatrophy caused by insulin therapy occurred.